Matritech Inc. / Adelaide SA / Medline / PURPOSE AND TARGET GROUP / USE Limited / /
Country
United States / Australia / New Zealand / /
Currency
USD / /
Event
FDA Phase / /
Facility
University of Adelaide / /
Holiday
Commonwealth Day of Australia / /
IndustryTerm
health technology / diagnostic tools / literature search / subsequent improvements health technologies / /
MedicalCondition
cancers / then transitional cell cancer / urinary tract disease / cancer / disease / Bladder Neoplasms/ urine Carcinoma / urinary tract infection / urothelial cell cancers / bladder cancer / tumour / carcinoma / malignant neoplasm / muscle-invasive disease / injury / removed tumours / suspected bladder cancer / urothelial cancer / CLINICAL NEED AND BURDEN OF DISEASE Bladder cancer / People Living With Cancer / non-muscle invasive bladder transitional cell carcinoma / stage Ta tumours / superficial bladder cancer / tumours / /
Organization
Health Policy Advisory Committee on Technology / National Horizon Scanning Unit / THERAPEUTIC GOODS ADMINISTRATION / Commonwealth Copyright Administration / University of Adelaide / Adelaide / Department of Health / American Society of Clinical Oncology / Australian Health Ministers’ Advisory Council / Medical Services Advisory Committee / Attorney General’s Department / United States Food and Drug Administration / Medicare / /
Person
Janet Hiller / Adrian Purins / /
Position
Governor / Professor / /
Product
NMP22 / United States / /
ProgrammingLanguage
DC / /
Technology
health technology / x-ray / hybridization / subsequent improvements health technologies / Horizon Scanning Technology / /
Horizon Scanning Technology Prioritising Summary BladderChek: diagnostic test for bladder cancer Update: August 2007